ANA SEGARRA-BRECHTEL: Open Payments
NPI 1952596157 · SUWANEE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 17 payments from 8 companies in 2025. Trend: 2023 $572 · 2024 $300 · 2025 $350
Food & beverage: $350
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $168 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Tris Pharma Inc | 1 | $18 |
Products named: VRAYLAR, COBENFY, Jornay PM, Auvelity, REXULTI, CAPLYTA, HETLIOZ, Dyanavel XR.
Industry payments across GA — which companies pay providers there.
